Patents by Inventor Johann Soret

Johann Soret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
    Patent number: 7989467
    Abstract: The invention relates to indole-derived compounds and to the use of said compounds for the preparation of a medicament that can be used to treat diseases related to the process of splicing pre-messenger RNAs in the cell, such as Frasier syndrome, frontotemporal dementia linked to chromosome 17 (a form of Parkinson's disease), Leigh syndrome (a type of encephalopathy), atypical cystic fibrosis, certain neuropathologies including Alzheimer's disease linked to a mutation in the Tau protein, muscle atorphy which affects the SMN (Survival of Motor Neuron) gene, depression linked to a serotonin splicing impairment, and certain cancers in which the global splicing process is affected (e.g. breast cancer, colon cancer and certain lymphomas), as well as viral diseases such as AIDS.
    Type: Grant
    Filed: September 6, 2004
    Date of Patent: August 2, 2011
    Assignees: Centre National de la Recherche Scientifique (CNRS), Universite Montpellier II, Institut Curie
    Inventors: Jamal Tazi, Johann Soret, Philippe Jeanteur, David Grierson, Christian Rivalle, Emile Bisagni, Chi Hung Nguyen
  • Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
    Publication number: 20070054905
    Abstract: The invention relates to indole-derived compounds and to the use of said compounds for the preparation of a medicament that can be used to treat diseases related to the process of splicing pre-messenger RNAs in the cell, such as Frasier syndrome, frontotemporal dementia linked to chromonsoem 17 (a form of Parkinson's disease), Leigh syndrome (a type of encephalopathy), atypical cystic fibrosis, certain neuropathologies including Alzheimer's disease linked to a mutation in the Tau protein, muscle atorphy which affects the SMN (survival of Motor Neuron) gene, depression linked to a serotonin splicing impairment, and certain cancers in which the global splicing process is affected (e.g. breast cancer, colon cancer and certain lymphomas), as well as viral diseases such as AIDS.
    Type: Application
    Filed: September 6, 2004
    Publication date: March 8, 2007
    Applicants: Centre National de la Recherche Scientifique (CNRS), Universite Montpellier ll Place Eugene Batallion, Institut Curie
    Inventors: Jamal Tazi, Johann Soret, Philippe Jeanteur, David Grierson